APPLIED THERAPEUTICS INC. - COMMON STOCK

Applied Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference

10 Feb 2022 04:00:00 By Nasdaq GlobeNewswire

Applied Therapeutics Provides Regulatory Update on Galactosemia Program

03 Jan 2022 04:00:00 By Nasdaq GlobeNewswire

Applied Therapeutics Announces Initiation of Registrational Phase 2/3 Study of AT-007 in SORD Deficiency

16 Dec 2021 04:00:00 By Nasdaq GlobeNewswire

Applied Therapeutics to Present at the 14th International Congress of Inborn Errors of Metabolism

18 Nov 2021 04:00:02 By Nasdaq GlobeNewswire

Applied Therapeutics Reports Biomarker Data from Pilot Trial of AT-007 in SORD Deficiency

25 Oct 2021 04:00:00 By Nasdaq GlobeNewswire

Applied Therapeutics Reports Additional Pediatric Biomarker Data from ACTION-Galactosemia Kids

18 Oct 2021 04:00:01 By Nasdaq GlobeNewswire

Applied Therapeutics Reports Initial Pediatric Biomarker Data from ACTION-Galactosemia Kids

09 Sep 2021 04:00:01 By Nasdaq GlobeNewswire

Applied Therapeutics Reports Second Quarter 2021 Financial Results

12 Aug 2021 04:00:02 By Nasdaq GlobeNewswire

Applied Therapeutics Added to Russell Microcap® Index

28 Jun 2021 04:00:00 By Nasdaq GlobeNewswire

Applied Therapeutics Announces Presentation of Data on the Prevalence of Diabetic Cardiomyopathy at the 81st Scientific Sessions of the 2021 Annual Meeting of the American Diabetes Association

25 Jun 2021 09:05:54 By Nasdaq GlobeNewswire

Applied Therapeutics to Present on Diabetic Cardiomyopathy and Prevalence of Disease at the 81st Scientific Sessions of the 2021 Annual Meeting of the American Diabetes Association

21 Jun 2021 04:00:00 By Nasdaq GlobeNewswire

Applied Therapeutics Granted Fast Track Designation by FDA for AT-007 for Galactosemia

17 Jun 2021 04:00:00 By Nasdaq GlobeNewswire

Applied Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

01 Jun 2021 04:00:00 By Nasdaq GlobeNewswire

Applied Therapeutics to Present at the UBS Global Healthcare Virtual Conference

19 May 2021 04:00:00 By Nasdaq GlobeNewswire

Applied Therapeutics Reports First Quarter 2021 Financial Results

11 May 2021 04:00:02 By Nasdaq GlobeNewswire

Applied Therapeutics to Present Cross-Sectional Analysis of Galactosemia Disease Progression at 2021 Annual Clinical Genetics Meeting of the American College of Medical Genetics and Genomics

07 Apr 2021 04:00:00 By Nasdaq GlobeNewswire

Applied Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results

18 Mar 2021 04:00:01 By Nasdaq GlobeNewswire

Applied Therapeutics to Host Virtual Rare Disease Forum

16 Mar 2021 04:00:00 By Nasdaq GlobeNewswire

Applied Therapeutics to Present at the Cowen and Barclays Investor Conferences

23 Feb 2021 04:00:01 By Nasdaq GlobeNewswire

Applied Therapeutics, Inc. Announces Closing of Public Offering

22 Feb 2021 04:00:00 By Nasdaq GlobeNewswire